Element

RfDing

RfDinh

RfDderm

Inh SF

DI

HQ

HI

LADD

CR

( µg kg BW 1 d 1 )

Children

Adult

Children

Adult

Children

Adult

Cdnon-cancer

1.0E−03

1.0E−03

5.0E−05

Ingestion

3.2E−05

3.4E−06

3.2E−02

3.4E−03

0.034

0.004

Inhalation

8.8E−10

5.0E−10

8.8E−07

5.0E−07

Dermal

8.8E−08

1.3E−08

1.8E−03

2.6E−04

Cdcancer

6.2

2.5E−10

1.6E−09

Pb

3.5E−03

3.52E−03

5.25E−04

Ingestion

6.4E−04

6.9E−05

1.8E−01

1.9E−02

0.184

0.020

Inhalation

1.8E−08

1.0E−08

5.1E−06

3.0E−06

Dermal

1.8E−06

2.7E−07

3.5E−03

5.1E−04

Mn

4.6E−02

1.43E−05

1.84E−03

Ingestion

2.8E−03

3.0E−04

6.1E−02

6.5E−03

0.071

0.010

Inhalation

7.7E−08

4.4E−08

5.4E−03

3.1E−03

Dermal

7.7E−06

1.2E−06

4.2E−03

6.5E−04

Ninon-cancer

2.0E−02

2.06E−02

5.4E−03

Ingestion

1.3E−04

1.4E−05

6.5E−03

7.0E−04

0.007

0.001

Inhalation

3.7E−09

2.1E−09

1.8E−07

1.0E−07

Dermal

3.8E−07

5.7E−08

7.0E−05

1.1E−05

Nicancer

0.84

1.0E−09

8.9E−11